 UAB News | New Renal Test for Quest Diagnostics - Analyst Blog NASDAQ Quest Diagnostics ( DGX ), a leading player in the diagnostic testing market, recently launched the world's first-of-its-kind molecular Renal Transplant Monitoring test to identify renal organ-transplant rejection. Quest claims that this test can ... Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant ... |
